What is the difference between chemotherapy and immunotherapy

Chemotherapy vs. Immunotherapy: How They Work Differently

These are two fundamentally different approaches to treating cancer, and understanding the distinction can help you have better conversations with your care team.

Chemotherapy: Direct Cell Damage

Chemotherapy works by directly attacking and killing cancer cells. Think of it like a broad-spectrum weapon—it targets cells that divide rapidly, which is a hallmark of cancer. However, because some normal cells also divide quickly (like hair follicles and cells lining your digestive tract), chemotherapy can affect those too, which is why side effects like hair loss and nausea are common.

How it works:

• Damages cancer cell DNA or interferes with cell division
• Works relatively quickly—cancer cells begin dying within days or weeks
• Effectiveness doesn't depend on the patient's immune system

Immunotherapy: Activating Your Immune System

Immunotherapy takes a different approach. Instead of directly killing cancer cells, it "wakes up" your own immune system to recognize and attack cancer. Your immune system naturally has the ability to fight abnormal cells, but cancer is clever at hiding from it. Immunotherapy removes those hiding spots.

How it works:

• Removes the "brakes" cancer puts on your immune system
• Helps your T-cells (immune fighters) recognize cancer as a threat
• Works through your body's own defense mechanisms
• May take longer to show effects, but can provide longer-lasting responses

Key Practical Differences

| Aspect | Chemotherapy | Immunotherapy | |--------|--------------|----------------| | Mechanism | Directly kills cells | Activates immune system | | Timeline | Faster initial response | Slower, but potentially durable | | Side effects | Nausea, hair loss, low blood counts | Fatigue, skin reactions, autoimmune effects | | Who benefits | Broad patient population | Works better for certain cancer types/biomarkers |

Important Context

According to NCCN (National Comprehensive Cancer Network) Guidelines, many cancer treatment plans now combine both approaches. For example, some patients receive chemotherapy followed by immunotherapy, or the two are given together. Your oncologist will determine which approach—or combination—makes sense based on:

• Your specific cancer type and stage
• Biomarkers (like PD-L1 status or tumor mutational burden)
• Your overall health and organ function
• Previous treatments you've received

The American Cancer Society emphasizes that the choice between these therapies is highly individualized and depends on your complete clinical picture.

Questions to Ask Your Doctor

If your care team is recommending one or both of these approaches:

1. Why is chemotherapy/immunotherapy recommended for my specific cancer?
2. What biomarkers or test results support this recommendation?
3. What are the expected side effects, and how will they be managed?
4. If one approach is recommended, why not the other?
5. What does success look like, and how will we measure response?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.